Matthew W. Foehr
2012 - Ligand Pharmaceuticals
In 2012, Matthew W. Foehr earned a total compensation of $1.2M as Executive VP and Chief Operating Officer at Ligand Pharmaceuticals, a 13% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $179,813 |
|---|---|
| Option Awards | $535,482 |
| Salary | $359,625 |
| Stock Awards | $144,700 |
| Other | $2,540 |
| Total | $1,222,160 |
Foehr received $535.5K in option awards, accounting for 44% of the total pay in 2012.
Foehr also received $179.8K in non-equity incentive plan, $359.6K in salary, $144.7K in stock awards and $2.5K in other compensation.
Rankings
In 2012, Matthew W. Foehr's compensation ranked 5,361st out of 11,487 executives tracked by ExecPay. In other words, Foehr earned more than 53.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,361 out of 11,487 | 53rd |
Division Manufacturing | 1,883 out of 4,253 | 56th |
Major group Chemicals And Allied Products | 454 out of 1,203 | 62nd |
Industry group Drugs | 301 out of 925 | 68th |
Industry Pharmaceutical Preparations | 234 out of 700 | 67th |
Source: SEC filing on March 12, 2015.
Foehr's colleagues
We found four more compensation records of executives who worked with Matthew W. Foehr at Ligand Pharmaceuticals in 2012.